What is a stock summary page? Click here for an overview.
Business Description
Nuwellis Inc
NAICS : 334517
SIC : 3845
ISIN : US12542Q5080
Description
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.35 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -41.83 | |||||
| Beneish M-Score | -6.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -88.2 | |||||
| 3-Year EBITDA Growth Rate | 92.5 | |||||
| 3-Year EPS without NRI Growth Rate | 89.5 | |||||
| 3-Year FCF Growth Rate | 90.7 | |||||
| 3-Year Book Growth Rate | -94.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 41.34 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.33 | |||||
| 9-Day RSI | 36.65 | |||||
| 14-Day RSI | 37.56 | |||||
| 3-1 Month Momentum % | 1.69 | |||||
| 6-1 Month Momentum % | -18.92 | |||||
| 12-1 Month Momentum % | -91.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.46 | |||||
| Quick Ratio | 2.79 | |||||
| Cash Ratio | 1.99 | |||||
| Days Inventory | 230.56 | |||||
| Days Sales Outstanding | 62.55 | |||||
| Days Payable | 290.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1033.9 | |||||
| Shareholder Yield % | -176.22 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.94 | |||||
| Operating Margin % | -125.72 | |||||
| Net Margin % | -127.75 | |||||
| FCF Margin % | -110.42 | |||||
| ROE % | -800.59 | |||||
| ROA % | -142.36 | |||||
| ROIC % | -378.41 | |||||
| 3-Year ROIIC % | -511.89 | |||||
| ROC (Joel Greenblatt) % | -294.17 | |||||
| ROCE % | -133.1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.06 | |||||
| PB Ratio | 0.64 | |||||
| Price-to-Tangible-Book | 0.64 | |||||
| EV-to-EBIT | 0.03 | |||||
| EV-to-EBITDA | 0.03 | |||||
| EV-to-Revenue | -0.02 | |||||
| EV-to-Forward-Revenue | 0.03 | |||||
| EV-to-FCF | 0.02 | |||||
| Price-to-GF-Value | 1.02 | |||||
| Price-to-Net-Current-Asset-Value | 0.76 | |||||
| Price-to-Net-Cash | 2.4 | |||||
| Earnings Yield (Greenblatt) % | 3333.33 | |||||
| FCF Yield % | -229.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NUWE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nuwellis Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8.74 | ||
| EPS (TTM) ($) | -38.55 | ||
| Beta | -0.09 | ||
| 3-Year Sharpe Ratio | -1.13 | ||
| 3-Year Sortino Ratio | -1.57 | ||
| Volatility % | 133.81 | ||
| 14-Day RSI | 37.56 | ||
| 14-Day ATR ($) | 0.088815 | ||
| 20-Day SMA ($) | 1.11409 | ||
| 12-1 Month Momentum % | -91.09 | ||
| 52-Week Range ($) | 0.9 - 14.346499 | ||
| Shares Outstanding (Mil) | 4.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nuwellis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nuwellis Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nuwellis Inc Frequently Asked Questions
What is Nuwellis Inc(NUWE)'s stock price today?
The current price of NUWE is $0.96. The 52 week high of NUWE is $14.35 and 52 week low is $0.90.
When is next earnings date of Nuwellis Inc(NUWE)?
The next earnings date of Nuwellis Inc(NUWE) is .
Does Nuwellis Inc(NUWE) pay dividends? If so, how much?
Nuwellis Inc(NUWE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers